Neuroscience drug startup Rodin Therapeutics Inc. has agreed to be acquired by Alkermes PLC for up to $950 million, showing the continued strong …
Link to Full Article: Read Here
Nov 18, 2019 | News Stories
Neuroscience drug startup Rodin Therapeutics Inc. has agreed to be acquired by Alkermes PLC for up to $950 million, showing the continued strong …
Link to Full Article: Read Here